The impact of adjuvant therapy on survival for node-negative esophageal squamous cell carcinoma: a propensity score- matched analysis

Xuyang Deng, Wenwu He, Yingchun Jiang, Sijie Deng, Tianqin Mao, Xuefeng Leng, Qiyu Luo, Kai Zheng, Yongtao Han

Annals of Translational Medicine · 2021 · 12 citations · 13 references

DOIFull text

Open access

Abstract

Adjuvant therapy, especially chemotherapy, prolonged OS and DFS for patients with ESCC who had pN0 disease. Fewer lymph node dissections and T3 stage tumors were independent risk factors for OS and DFS.

References

13